MedTrace Logo

Effect of Electroacupuncture on Premenstrual Syndrome in Young Women

NCT07737210 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-07-30

No results posted yet for this study

Summary

The aim of this study was to determine the effect of electroacupuncture on premenstrual syndrome in young women.

Conditions

Interventions

DIETARY_SUPPLEMENT

Nutritional Supplement

The participants received daily nutritional supplementation for three consecutive menstrual cycles, consisting of calcium 800-1000 mg/day, magnesium 250 mg/day, vitamin B6, and zinc 10 mg/day.

DEVICE

electroacupuncture

* Total number of electroacupuncture sessions: 21 sessions. * Schedule: 7 consecutive daily sessions during each menstrual cycle for 3 consecutive cycles. * Timing in each cycle: treatment started 3 days before the expected onset of menstruation and continued through the fourth day of menstruation. * Session duration: approximately 20-30 minutes. * Needle specification used in the actual procedure: sterile filiform needles, 0.30 mm × 40 mm. * Needle sensation: insertion was performed to elicit Deqi. * Electrical stimulation device: TensCare; dense-wave mode. * Acupuncture points: LI4 (Hegu), LI11 (Quchi), P6 (Neiguan), LIV3/LR3 (Taichong), SP6 (Sanyinjiao), ST36 (Zusanli), DU20 (Baihui), REN2 (Qugu), REN6 (Qihai), and REN12 (Zhongwan).

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Hossam Kamel, professor · Al-Azhar University

  • Abeer El-Deeb, professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
29 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2025-12-26
Completion
2026-01-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07737210 on ClinicalTrials.gov